Skip to content
Screener

Cytek Biosciences, Inc. CTKB United States — Total revenue, net

Other geography segments

China
$3.6M

Similar metrics at other companies

Viavi Solutions Inc. logo
VIAVUnited States — Total net revenue
$154M+71.3%
Take-Two Interactive Software logo
TTWOUnited States — Total net revenue
$920M+2.2%
Freedom Holding logo
FRHCUnited States — TOTAL REVENUE, NET
$2.34M-59.6%
A10 Networks logo
ATENUnited States — Total net revenue
$51.76M+35.1%
Dell Technologies logo
DELLUnited States — Total net revenue
$15.79B+23.8%
ALH
ALHUnited States — Total Net revenues
$340.22M+13.8%

Other financials

Income statement

See full
Revenue$48.1M+5.6%
Gross profit$28.3M+18.7%
Operating income-$11.4M-7.3%
Net income-$12.2M-118%
EPS (diluted)-$0.09-125%

Balance sheet

See full
Cash & equivalents$73.8M-2.2%
Total debt$17.0M-6.6%
Total equity$322.0M-14.7%
Total assets$446.9M-9.4%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+40.5%
Free cash flow-$849.0K+42.2%

Valuation

See full
Market cap$545.93M+25.6%
Enterprise value$489.11M+29.2%
P/S2.6×+0.4×

Profitability

See full
Gross margin53.2%-1.2pp
Operating margin-21.6%
Net margin-39%
FCF margin-5.8%-11.4pp

Returns & leverage

See full
Return on equity-23%
Debt / equity0.1×0.0×
Current ratio4.5×-0.7×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053496
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
United States$28,220$23,894$52,607$42,429
EMEA11,30412,30922,06923,875
APAC7,9157,86715,66616,758
Other7011,5321,9333,997
Total revenue, net$48,140$45,602$92,275$87,059

Item 1. Consolidated Financial Statements (Unaudited)

FAQ

What is Cytek Biosciences, Inc.'s united states — total revenue, net?
Cytek Biosciences, Inc. (CTKB) reported united states — total revenue, net of $28.22M in Q2 2026.
How has Cytek Biosciences, Inc.'s united states — total revenue, net changed year-over-year?
Cytek Biosciences, Inc.'s united states — total revenue, net increased by 18.1% year-over-year, from $23.9M to $28.22M.
What is the long-term trend for Cytek Biosciences, Inc.'s united states — total revenue, net?
Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s united states — total revenue, net has grown at a 7.0% compound annual growth rate (CAGR), from $72.72M to $95.26M.
What does united states — total revenue, net mean?
This metric represents the total net revenue generated from product sales and services within the United States geographic region. It reflects the company's market penetration and demand for its specialized analytical instrumentation and associated consumables in this specific territory. Tracking this figure helps investors assess regional growth trends and the effectiveness of local commercial operations.

Ask your AI about Cytek Biosciences, Inc.'s united states — total revenue, net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude